webinar register page

Webinar banner
Progress and Promise 2022: A Year-End Report
This is it! Our year-end summary of how research, led by Lustgarten, is transforming pancreatic cancer into a curable disease.

Join Lustgarten CEO Linda Tantawi and Andrew Rakeman, Vice President of Research, for an in-depth analysis with David Tuveson and Elizabeth Jaffee.

Join us on THURSDAY, DECEMBER 8

Dec 8, 2022 11:15 AM in Eastern Time (US and Canada)

* Required information
Loading